Divi's Laboratories Limited has informed the Exchange regarding Appointment of Mr Nimmagadda Venkata Anirudh as President (Nutraceuticals) and Senior Management Personnel of the company w.e.f. November 07, 2025.
DIVISLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Divi's Laboratories has appointed Mr Nimmagadda Venkata Anirudh as President of its Nutraceuticals division and as a Senior Management Personnel, effective November 7, 2025. The appointment indicates the company is strengthening its leadership in the nutraceuticals segment, which is an area of growing focus. No further details on his background or prior roles were provided in this filing. This is a routine senior management appointment disclosed to the exchange.
This is a routine leadership appointment and is unlikely to have an immediate impact on the stock price. It signals continued investment in the company's nutraceuticals business, which could be a positive long-term growth indicator for shareholders.